Part 1: Agency Collaboration in Health Technology Assessment

06-03-19DRG Admin

The US-based, independently operated Institute for Clinical and Economic Review (ICER) has established a partnership with the UK’s National Institute for Health Care and Excellence (NICE) and the Canadian Agency for Drugs and Technologies in Health (CADTH), on how to measure value for high-cost gene therapies. What does this mean for the industry? DRG's experts on Global Market Access discuss this collaboration and potential impacts to the industry.

We are part of Clarivate, a global leader in providing trusted insights and analytics to accelerate the pace of innovation.

Our Company
© DRG Abacus 2020